Effect of race on the safety and efficacy of pemetrexed (P) therapy in locally advanced and metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Tai, D. F. [1 ]
Kulkarni, P. [1 ]
Wang, Y. [1 ]
Gill, J. [1 ]
Obasaju, C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18082
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
    Greenhalgh, J.
    McLeod, C.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    Dundar, Y.
    Oyee, J.
    Dickson, R.
    Davis, H.
    Green, J.
    McKenna, E.
    Pearson, M.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 33 - 39
  • [2] Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
    Cohen, Martin H.
    Cortazar, Patricia
    Justice, Robert
    Pazdur, Richard
    [J]. ONCOLOGIST, 2010, 15 (12): : 1352 - 1358
  • [3] Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
    Velez, Michel
    Arango, Belisario A.
    Perez, Cesar A.
    Santos, Edgardo S.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 117 - 124
  • [4] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [5] Review of pemetrexed with platinum chemotherapy for locally advanced or metastatic non squamous non-small cell lung cancer (NSCLC) in Northern Ireland
    Forde, C.
    Healy, R.
    Campbell, L.
    Scullin, R.
    [J]. LUNG CANCER, 2014, 83 : S13 - S13
  • [6] Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma
    Lee, Gyu Jin
    Jung, Mann Hong
    Jang, Tae Won
    Ok, Chul Ho
    Jung, Hyun Joo
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 67 (02) : 121 - 126
  • [7] Safety and efficacy of pemetrexed as monotherapy for the maintenance treatment of metastatic non-small cell lung cancer
    Aparicio Rubio, C.
    Cornejo Uixeda, S.
    Prieto Castello, M.
    Monteagudo Santolaya, E.
    Antonino de la Camara, G.
    Quintana Vergara, B.
    Sanchez Alcaraz, A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 373 - 373
  • [8] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [9] Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)
    Raez, Luis E.
    Santos, Edgardo S.
    Lopes, Gilberto
    Rosado, Manuel F.
    Negret, Lawrence M.
    Rocha-Lima, Caio
    Tolba, Kalhed
    Farfan, Nancy
    Hamilton-Nelson, Kara
    Silva, Orlando
    Roman, Eloy
    [J]. LUNG CANCER, 2006, 53 (03) : 347 - 353
  • [10] Palliative thoracic radiotherapy in locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Maclennan, K.
    Campbell, S.
    Little, F.
    Erridge, S.
    Evans, T.
    Price, A.
    [J]. LUNG CANCER, 2016, 91 : S53 - S54
12345